1. Zhou et al. Current approaches for the treatment of ketamine‐induced cystitis. Neurourol Urodyn 2023; 42:680–689. https://doi.org/10.1002/nau.25148
2. Winstock AR, Mitcheson L, Gillatt DA, Cottrell AM. The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU Int 2012; 110: 1762–66. https://doi.org/10.1111/j.1464-410x.2012.11028.x
3. Lindsay J & Wood D. Ketamine uropathy – an update. Urology News 2020. https://www.urologynews.uk.com/features/features/post/ketamine-uropathy-an-update
4. Wood D et al. Recreational ketamine: from pleasure to pain. BJU Int 2011; 107: 1881-1884. https://doi.org/10.1111/j.1464-410x.2010.10031.x
5. Belal M et al. British Association of Urological Surgeons Consensus statements on the management of ketamine uropathy. BJU Int 2024. https://doi.org/10.1111/bju.16404
6. Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anaesthesia and pain therapy. Clin Pharmacokinet 2016; 55: 1059–77. https://doi.org/10.1007/s40262-016-0383-6
7. Leaver R. Ketamine bladder: what community nurses should know. Urology and Continence Care Today 2024. https://www.ucc-today.com/journals/issue/launch-edition/article/ketamine-bladders-what-community-nurses-should-know-ucct
8. Oxley JD, Cottrell AM, Adams S, Gillatt D. Ketamine cystitis as a mimic of carcinoma in situ. Histopathology 2009; 55(6):705-8. https://doi.org/10.1111/j.1365-2559.2009.03437.x
9. Wu P et al. Clinical staging of ketamine-associated urinary dysfunction: a strategy for assessment and treatment. World J Urol 2016; 34(9):1329-36. https://doi.org/10.1007/s00345-016-1759-9
